FERTIGYN 5000 is a human chorionic gonadotropin (hCG) injection containing 5,000 international units (IU) of the hormone. hCG is closely related to luteinizing hormone (LH) and plays a key role in regulating reproductive processes. In women undergoing fertility treatment, a moderate dose of hCG like FERTIGYN 5000 is used to trigger final follicular maturation and ovulation following ovarian stimulation with follicle-stimulating drugs. It promotes the release of a mature egg from the ovary, aiding in assisted reproductive procedures such as intrauterine insemination (IUI) or in vitro fertilization (IVF). In men, hCG injections are used to stimulate Leydig cells in the testes, increasing testosterone production and supporting spermatogenesis in cases of hypogonadism or infertility, and to induce the descent of testicles in boys with cryptorchidism.
FERTIGYN 5000 should always be administered by a healthcare professional in a clinical setting. The dosage and timing depend on the specific condition being treated: women usually receive a single dose in the mid-cycle after follicular monitoring, while men may receive injections several times per week over a prescribed course. Self-administration should only occur if properly trained and under physician supervision.
Potential side effects include discomfort at the injection site, headaches, fatigue, irritability or mood changes. Women undergoing fertility treatment may experience abdominal bloating, nausea or mild fluid retention; rarely, ovarian hyperstimulation syndrome (OHSS) can occur. Men may experience water retention, acne or breast tenderness. Because hCG can increase androgen and estrogen levels, individuals with hormone-sensitive cancers should avoid its use. Always inform your doctor of any medications or health conditions prior to starting therapy.
When used appropriately, FERTIGYN 5000 helps support reproductive functions and hormone regulation in both men and women, contributing to successful fertility treatments and hormone balance.
FERTIGYN 5000 should always be administered by a healthcare professional in a clinical setting. The dosage and timing depend on the specific condition being treated: women usually receive a single dose in the mid-cycle after follicular monitoring, while men may receive injections several times per week over a prescribed course. Self-administration should only occur if properly trained and under physician supervision.
Potential side effects include discomfort at the injection site, headaches, fatigue, irritability or mood changes. Women undergoing fertility treatment may experience abdominal bloating, nausea or mild fluid retention; rarely, ovarian hyperstimulation syndrome (OHSS) can occur. Men may experience water retention, acne or breast tenderness. Because hCG can increase androgen and estrogen levels, individuals with hormone-sensitive cancers should avoid its use. Always inform your doctor of any medications or health conditions prior to starting therapy.
When used appropriately, FERTIGYN 5000 helps support reproductive functions and hormone regulation in both men and women, contributing to successful fertility treatments and hormone balance.
0